Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D. Wiviott, Marc S. Sabatine, Itamar Raz et al.|New England Journal of Medicine|2018Cited by 6.3k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Jennifer B. Green et al.|The Lancet|2018Cited by 1.8k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetesNikolaus Marx, Konstantinos C. Koskinas, Andrew J.S. Coats et al.|European Heart Journal|2023Cited by 1.4k
Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General PopulationJames A. de Lemos, Darren K. McGuire|JAMA|2010Cited by 1.1k
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular RiskStephen J. Nicholls, Steven E. Nissen, A. Michael Lincoff et al.|JAMA|2020Cited by 981